Sorafenib Versus Best Supportive Care in Egyptian Hepatocellular Carcinoma Patients. Prospective Phase III Study
Phase of Trial: Phase III
Latest Information Update: 19 Feb 2018
At a glance
- Drugs Sorafenib (Primary)
- Indications Liver cancer
- Focus Adverse reactions; Therapeutic Use
- 13 Feb 2018 Status changed from recruiting to completed.
- 15 Mar 2017 Status changed from not yet recruiting to recruiting.
- 25 Nov 2016 New trial record